Clinical Trial Update: Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium [Phase 1]

View source ↗

Summary

A Phase 1 pilot trial compared xanomeline alone to xanomeline plus trospium in people with schizophrenia and has completed. The study was sponsored by Karuna Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Trospium (trospium)
• Xanomeline (Xanomeline)

Snippet

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED